Founded with a mission to combat the epidemic of counterfeit medications in low- to middle-income countries, VeriPAD is a for-profit startup dedicated to improving health outcomes through innovative technology. The company offers an app and a chemical testing tool that empower patients to verify the authenticity of their medications easily and accurately. With an estimated 20%-50% of medications in developing countries being counterfeit, VeriPAD aims to make a significant impact on public health by providing accessible and reliable solutions.
VeriPAD has garnered attention and support from notable figures and investors in the health tech industry. The startup has achieved significant milestones, including successful pilot programs and partnerships with healthcare organizations in affected regions. By addressing a critical issue that affects millions daily, VeriPAD is making strides in enhancing the quality of health and safety for individuals in developing countries.
